Dermatologic Emergencies
Diagnosing And Managing Life-Threatening Rashes
- Nguyen, Thomas MD
- Freedman, Jessica MD
- Burke, Marianne C. MD
- Playe, Stephen J. MD, FACEP
March 15, 2001: You see a patient for “fatigue.” This 52-year-old man was recently discharged from the hospital on ticlopidine and methyldopa. When you enter the room, he is fully clothed in a suit and tie—another violation of the ED's “get naked” policy (which is more honored in breach than observance). He looks okay—he's certainly well-dressed, and through his coat, his lungs sound clear. Looks like another “viral syndrome.”
February 25, 2002: You receive an ominous-looking certified letter. The complaint is lengthy but you understand the gist. A patient you had seen almost a year ago died two days after his visit from an intracerebral bleed. The plaintiff's lawyers cite a triage note that documented complaints of “fatigue and rash”; your record did not mention a rash. The attached pathology report listed the cause of death as “medication-induced TTP.”